Showing results (851-860 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|November 5, 2003
Mometasone furoate degradation and metabolism in human biological fluids and tissuesXiao Wei Teng, David J Cutler, Neal M DaviesBiopharmaceutics & Drug Disposition|November 5, 2003
Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2Akihiro Inano, Yoshimichi Sai, Hiroko Nikaido, et al.Biopharmaceutics & Drug Disposition|July 1, 1991
Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA dosesS H Curry, A Lorenz, P I Chu, et al.Biopharmaceutics & Drug Disposition|February 16, 2010
Simulation of sirolimus exposures and population variability immediately post renal transplantation: importance of the patient's CYP3A5 genotype in tailoring treatmentJohn C Lukas, Rosario Calvo, Anastasios Zografidis, et al.Biopharmaceutics & Drug Disposition|June 14, 2017
SGK1/Nedd4-2 signaling pathway regulates the activity of human organic anion transporters 3Haoxun Wang, Guofeng YouBiopharmaceutics & Drug Disposition|July 19, 2018
Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicinesMiguel Ángel Cabrera-Pérez, Hai Pham-The, Mirna Fernández Cervera, et al.Biopharmaceutics & Drug Disposition|March 10, 2010
Simple pharmacometric tools for oral anti-diabetic drug development: competitive landscape for oral non-insulin therapies in type 2 diabetesMahesh N SamtaniBiopharmaceutics & Drug Disposition|April 22, 2018
Population pharmacokinetics of gliclazide in normal and diabetic rabbitsMastan Shaik, Shabana Shaik, Eswar Kumar KilariBiopharmaceutics & Drug Disposition|April 3, 2018
Amorphous solid dispersions of carvedilol along with pH-modifiers improved pharmacokinetic properties under hypochlorhydoriaShimul Halder, Aiko Tabata, Yoshiki Seto, et al.Biopharmaceutics & Drug Disposition|January 1, 1986
Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administrationR Jochemsen, P A van Rijn, T G Hazelzet, et al.Pageof 214